Mária Rečková

1.8k total citations
39 papers, 1.1k citations indexed

About

Mária Rečková is a scholar working on Surgery, Molecular Biology and Neurology. According to data from OpenAlex, Mária Rečková has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 15 papers in Molecular Biology and 13 papers in Neurology. Recurrent topics in Mária Rečková's work include Testicular diseases and treatments (20 papers), Neuroblastoma Research and Treatments (13 papers) and Sarcoma Diagnosis and Treatment (8 papers). Mária Rečková is often cited by papers focused on Testicular diseases and treatments (20 papers), Neuroblastoma Research and Treatments (13 papers) and Sarcoma Diagnosis and Treatment (8 papers). Mária Rečková collaborates with scholars based in Slovakia, United States and India. Mária Rečková's co-authors include David Sedmera, Robert G. Gourdie, Robert P. Thompson, Angela deAlmeida, Michal Mego, Jozef Mardiak, Daniela Světlovská, Zuzana Syčová-Milá, Jana Obertová and Andy Wessels and has published in prestigious journals such as Journal of Clinical Oncology, Circulation Research and Development.

In The Last Decade

Mária Rečková

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mária Rečková Slovakia	14	691	314	314	213	155	39	1.1k
A Schneider Germany	16	313 0.5×	231 0.7×	85 0.3×	90 0.4×	100 0.6×	31	1.0k
Jinzhu Duan China	12	734 1.1×	211 0.7×	266 0.8×	89 0.4×	102 0.7×	21	1.1k
Elizabeth Weihe United States	12	485 0.7×	78 0.2×	58 0.2×	231 1.1×	204 1.3×	24	921
Akitaka Yamamoto Japan	15	469 0.7×	173 0.6×	38 0.1×	118 0.6×	98 0.6×	42	1.0k
Santiago Serrano Spain	12	409 0.6×	205 0.7×	49 0.2×	57 0.3×	227 1.5×	22	780
Alistair J. Watt United States	13	1.2k 1.8×	494 1.6×	245 0.8×	112 0.5×	108 0.7×	15	1.7k
Valerié Schumacher Germany	24	1.4k 2.1×	210 0.7×	25 0.1×	284 1.3×	82 0.5×	36	1.8k
A.E. Greijer Netherlands	8	626 0.9×	108 0.3×	27 0.1×	90 0.4×	209 1.3×	10	1.2k
Kelly M. Credille United States	22	400 0.6×	95 0.3×	57 0.2×	107 0.5×	209 1.3×	52	1.0k
Guillermo Luxán Germany	15	955 1.4×	169 0.5×	423 1.3×	150 0.7×	93 0.6×	27	1.3k

Countries citing papers authored by Mária Rečková

Since Specialization

Citations

This map shows the geographic impact of Mária Rečková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mária Rečková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mária Rečková more than expected).

Fields of papers citing papers by Mária Rečková

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mária Rečková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mária Rečková. The network helps show where Mária Rečková may publish in the future.

Co-authorship network of co-authors of Mária Rečková

This figure shows the co-authorship network connecting the top 25 collaborators of Mária Rečková. A scholar is included among the top collaborators of Mária Rečková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mária Rečková. Mária Rečková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rečková, Mária, et al.. (2024). Cancer epidemiology in Slovakia. Bratislavské lekárske listy/Bratislava medical journal. 125(12). 829–834. 1 indexed citations

Fizazi, Karim, Gwénaël Le Teuff, Aude Fléchon, et al.. (2024). Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial. Journal of Clinical Oncology. 42(28). 3270–3276. 4 indexed citations

Mego, Michal, Jozef Chovanec, Mária Rečková, et al.. (2024). The beneficial effect of probiotics in the prevention of irinotecan-induced diarrhea in colorectal cancer patients with colostomy: a pooled analysis of two probiotic trials (Probio-SK-003 and Probio-SK-005) led by Slovak Cooperative Oncology Group. Frontiers in Oncology. 14. 1438657–1438657. 4 indexed citations

Mego, Michal, Jozef Chovanec, Branislav Bystrický, et al.. (2023). Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients. Frontiers in Oncology. 13. 1168654–1168654. 10 indexed citations

Mego, Michal, Daniela Světlovská, Katarína Kaľavská, et al.. (2022). Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial. Investigational New Drugs. 40(5). 1080–1086. 18 indexed citations

Mego, Michal, Katarína Rejleková, Daniela Světlovská, et al.. (2021). Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial. European Urology Open Science. 33. 19–27. 2 indexed citations

Mego, Michal, Daniela Světlovská, Mária Rečková, et al.. (2021). Gemcitabine, carboplatin and veliparib in multiple relapsed/refractory germ cell tumours: The GCT-SK-004 phase II trial. Investigational New Drugs. 39(6). 1664–1670. 15 indexed citations

Mego, Michal, Daniela Světlovská, Michal Chovanec, et al.. (2019). Phase II study of avelumab in multiple relapsed/refractory germ cell cancer. Investigational New Drugs. 37(4). 748–754. 55 indexed citations

Rečková, Mária, et al.. (2017). Differences in Age-distribution, Oncological Diagnoses and Stage in Roma and Non-Roma Cancer Patients Registered at the Outpatient Oncology Department Poprad in 2014 and 2015 – a Retrospective Study. Klinicka onkologie. 30(1). 41–47.

10.

Fizazi, Karim, Aude Fléchon, Gwénaël Le Teuff, et al.. (2016). Mature results of the GETUG 13 phase III trial in poor-prognosis germ-cell tumors (GCT).. Journal of Clinical Oncology. 34(15_suppl). 4504–4504. 10 indexed citations

11.

Mego, Michal, Jozef Chovanec, Mária Rečková, et al.. (2015). Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study. Complementary Therapies in Medicine. 23(3). 356–362. 180 indexed citations

12.

Mego, Michal, Daniela Světlovská, Věra Miškovská, et al.. (2015). Phase II study of everolimus in refractory testicular germ cell tumors. Urologic Oncology Seminars and Original Investigations. 34(3). 122.e17–122.e22. 42 indexed citations

13.

Mego, Michal, Jozef Chovanec, Mária Rečková, et al.. (2014). Prevention of irinotecan-induced diarrhea by probiotics: Randomized double-blind, placebo-controlled phase III study.. Journal of Clinical Oncology. 32(15_suppl). 9611–9611. 2 indexed citations

14.

Rečková, Mária, Daniela Světlovská, Jana Obertová, et al.. (2012). Phase II Study of Everolimus (E) in Refractory Germ Cell Tumors (GCTS). Annals of Oncology. 23. ix293–ix293. 1 indexed citations

15.

Mego, Michal, Katarína Rejleková, Mária Rečková, et al.. (2009). Kinetics of tumor marker decline as an independent prognostic factor in patients with relapsed metastatic germ-cell tumors.. Neoplasma. 56(5). 398–403. 9 indexed citations

16.

Mardiak, Jozef, Zuzana Syčová-Milá, Jana Obertová, et al.. (2007). Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.. PubMed. 54(3). 240–5. 11 indexed citations

17.

Sedmera, David, et al.. (2005). Optical Mapping of Electrical Activation in the Developing Heart. Microscopy and Microanalysis. 11(3). 209–215. 25 indexed citations

18.

Sedmera, David, Mária Rečková, Angela deAlmeida, et al.. (2004). Developmental transitions in electrical activation patterns in chick embryonic heart. The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology. 280A(2). 1001–1009. 48 indexed citations

19.

Mardiak, J., Zuzana Syčová-Milá, Jana Obertová, et al.. (2004). Paclitaxel, ifosfamide, and cisplatin (TIP) salvage therapy for patients (pts) with relapsed testicular germ cell tumors (GCT). Journal of Clinical Oncology. 22(14_suppl). 4632–4632. 4 indexed citations

20.

Sedmera, David, Mária Rečková, Angela deAlmeida, et al.. (2003). Spatiotemporal pattern of commitment to slowed proliferation in the embryonic mouse heart indicates progressive differentiation of the cardiac conduction system. The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology. 274A(1). 773–777. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact